Nicotinamide for skin cancer chemoprevention

被引：24
|
作者：
Damian, Diona L. [1 ,2 ]
机构：
[1] Univ Sydney, Royal Prince Alfred Hosp, Cent Clin Sch, Discipline Dermatol, Sydney, NSW, Australia
[2] Melanoma Inst Australia, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2017年 / 58卷 / 03期
基金：
英国医学研究理事会;
关键词：
basal cell carcinoma; melanoma; niacinamide; squamous cell carcinoma; vitamin B-3; RADIATION-INDUCED IMMUNOSUPPRESSION; INDUCED DNA-DAMAGE; HIGH-DOSE NICOTINAMIDE; ULTRAVIOLET-RADIATION; PYRIMIDINE DIMERS; REPAIR; RISK; PHOTOCARCINOGENESIS; PREVENTION; NIACIN;
D O I：
10.1111/ajd.12631
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Nicotinamide (vitamin B-3) has a range of photoprotective effects in vitro and in vivo; it enhances DNA repair, reduces UV radiation-induced suppression of skin immune responses, modulates inflammatory cytokine production and skin barrier function and restores cellular energy levels after UV exposure. Pharmacological doses of nicotinamide have been shown to reduce actinic keratoses and nonmelanoma skin cancer incidence in high-risk individuals, making this a nontoxic and accessible option for skin cancer chemoprevention in this population.
引用
收藏
页码：174 / 180
页数：7
相关论文
共 50 条
  • [41] Nicotinamide for skin cancer chemoprevention: enhancement of DNA repair after ultraviolet and arsenic exposure by replenishing cellular energy
    Damian, D.
    Thompson, B.
    Kim, B.
    Halliday, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (03) : E78 - E78
  • [42] Nicotinamide for skin cancer chemoprevention: enhancement of DNA repair after ultraviolet and arsenic exposure by replenishing cellular energy
    Damian, D.
    Thompson, B.
    Kim, B.
    Halliday, G.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 66 - 66
  • [43] Chemoprevention of non melanoma skin cancer
    Chinniah, N.
    Damian, D. L.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 : 30 - 30
  • [44] Skin cancer chemoprevention: Strategies to save our skin
    Einspahr, JG
    Bowden, GT
    Alberts, DS
    TUMOR PREVENTION AND GENETICS, 2003, 163 : 151 - 164
  • [45] Nicotinamide chemoprevention trial success
    Lydia Shipman
    Nature Reviews Cancer, 2015, 15 (12) : 697 - 697
  • [46] Authors' response to a reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'
    Damian, D. L.
    Martin, A. J.
    Scolyer, R. A.
    Chen, A. C.
    Halliday, G. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 176 (02) : 552 - 553
  • [47] Oral nicotinamide for skin cancer prevention
    Damian, Diona
    Surjana, Devita
    Martin, Andrew
    Halliday, Gary
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S99 - S99
  • [48] Feasibility of a trial to evaluate nicotinamide for chemoprevention of skin cancers in organ transplant recipients in the UK
    Gollins, C. E.
    Shah, A.
    Sinha, K.
    Khan, S.
    Paul, N.
    Meeajun, B.
    Abbott, R. A.
    Blasdale, C.
    Cooper, H.
    Harwood, C. A.
    Ismail, F.
    Lear, J. T.
    Mackintosh, L.
    McCormack, S.
    Perrett, C. M.
    Proby, C. M.
    Durack, A.
    Patalay, R.
    Matin, R. N.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (02) : 394 - 396
  • [49] Feasibility of a trial to evaluate nicotinamide for chemoprevention of skin cancers in organ transplant recipients in the UK
    Gollins, C.
    Shah, A.
    Khan, S.
    Paul, N.
    Meeajun, B.
    Sinha, K.
    Durack, A.
    Patalay, R.
    Matin, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 132 - 132
  • [50] Chemoprevention of skin cancer through natural agents
    Gupta, S
    Mukhtar, H
    SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 2001, 14 (06): : 373 - 385
12345